Pfizer Prices US$5bn Bond As Corporate Debt Deluge Continues
March 05, 2019 at 15:00 PM EST
Pfizer said it will peg proceeds from the sale for general corporate purposes, including to refinance, redeem or repurchase existing debt and to repay a portion of its outstanding commercial paper.